World's first bioresorbable drug-eluting stent CE-marked in EU
This article was originally published in SRA
Executive Summary
The world's first fully dissolving drug-eluting stent (DES) has been CE marked for sale in Europe by its manufacturer, Abbott, for the treatment of coronary artery disease1.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.